Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPRESS: Endometrial Gene Expression with Gonal-f in ART
NCT01210144Phase 4Terminated
- Sponsor
- Merck KGaA
- Start
- Aug 2008
- Primary completion
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of follitropin alfa in infertility (2 arms), sponsored by Merck KGaA. Primary endpoints: Gene Expression of the Endometrium and Histological Pattern of the Endometrium. Started Aug 2008; status: terminated.
02
Drugs
follitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01210144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210144.